Savings Alert: We've added new, lower prices at most pharmacies for this prescription. Learn More
Elizabeth Davis - August 22, 2017
If you’ve got health insurance, now’s a good time to be paying attention. Each year, prescription coverage changes, and yours will likely be changing in 2018.
Express Scripts and Caremark, companies that handle pharmacy benefits for more than 200 million Americans, are removing more than 80 prescription medications from their formularies at the end of 2017. There is a silver lining for some of you though—almost 20 currently excluded drugs will be covered in 2018. See More
The GoodRx Pharmacist - June 21, 2017
This update is the result of new data from the CANVAS and CANVAS-R clinical trials. This research showed that leg and foot amputations occurred two times more often in patients treated with canagliflozin than in patients who were given a placebo sugar pill. See More
Dr. Sharon Orrange - November 09, 2016
Did you know that there are certain medications out there that can cause forms of kidney damage? Don’t get me wrong, these medications can be life altering, and even life saving – but they are known to directly affect kidney function.
Medications that can damage the kidneys are known as “nephrotoxic medications.” These drugs can cause direct toxicity to the kidneys, and have been implicated in up to 25% of acute kidney injuries. See More
Elizabeth Davis - September 17, 2015
Good news! In a just-published study, Jardiance (empagliflozin) for type 2 diabetes has been shown to reduce deaths from cardiovascular disease.
The results are impressive. Comparing Jardiance to a placebo, the study showed a 38% reduction in the risk of death from a cardiovascular cause (3.7% with Jardiance vs 5.9% with placebo). Jardiance was also shown to reduce the risk of any cardiovascular event (heart attack, stroke, or death) by 14%, and to reduce the risk of death from all causes by 32%. See More
The GoodRx Pharmacist - September 02, 2015
According to the 2014 National Diabetes Statistics Report from the CDC, 29.1 million people or 9.3% of the United States population has either type 1 or type 2 diabetes. That means that almost 1 in 11 Americans have diabetes!
With so many people affected, new medications are constantly being developed—especially to help treat type 2 diabetes, the most common form.
The GoodRx Pharmacist - May 21, 2015
On May 15, 2015, the FDA issued a warning for the newest class of diabetes medications, SGLT2 inhibitors.
According to the FDA, the medications in this class may lead to a serious and life-threatening condition known as ketoacidosis.
Which medications are considered SGLT2 inhibitors?
These medications also contain SGLT2 inhibitors in combination with other active ingredients:
- Glyxambi (empagliflozin/linagliptin)
- Invokamet (canagliflozin/metformin)
- Xigduo XR (dapagliflozin/metformin)
What should I do if I am taking one of these medications?
If you are taking one of the medications listed above DO NOT stop your medication without talking to your doctor. See More
The GoodRx Pharmacist - August 08, 2014
Jardiance (empagliflozin) was approved by the FDA on August 1, 2014 for the treatment of type 2 diabetes.
How does Jardiance work?
It works with the body’s natural process of urination to help remove more excess sugar from the body rather than allowing it to be reabsorbed by your kidneys. See More